✦ LIBER ✦

EGFR/KRAS Mutations and Gefitinib Therapy in Chinese NSCLC Patients

✍ Scribed by Wang, Zhen; Wu, Yi Long; Zhang, Guo Chun; Zhou, Qing; Xu, Chong Rui; Guo, Ai Lin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib effective for patients with NS

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

EGFR and KRAS mutations in Chinese patie

✍ Jia, Xiao-Li; Chen, Gang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Identification of EGFR and KRAS mutation

✍ Q.-W. Liu; J.-H. Fu; K.-J. Luo; H.-X. Yang; J.-Y. Wang; Y. Hu; H. Yang; E. Bella 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

128PD EGFR, KRAS, PIK3CA MUTATIONS AND R

✍ Crinò, L.; Pistola, L.; Bianconi, F.; Chiari, R.; Meacci, M.; Colella, R.; Giuff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

9162 EGFR, KRAS, PIK3CA mutations and re

✍ Chiari, R.; Ludovini, V.; Bianconi, F.; Pistola, L.; Colella, R.; Mameli, M.; Gi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Comparison of gefitinib and erlotinib in

✍ Wu, Jenn-Yu; Wu, Shang-Gin; Yang, Chih-Hsin; Chang, Yih-Leong; Chang, Yeun-Chung 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 152 KB